Krystal Biotech, Inc.
NASDAQ:
KRYS
Krystal Biotech, Inc. (NASDAQ: KRYS) is a biotechnology company specializing in genetic medicines for rare diseases. Leveraging its proprietary redosable HSV vector platform, the company develops innovative therapies across a diverse pipeline. Headquartered
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
US Equity Report
A$5000.00
Already a subscriber?
Sign in to read this report.
Required subscription
US Equity Report
Expand beyond the ASX with expert research on carefully selected U.S. stocks, covering market leaders, emerging opportunities, and global investment trends.
- ✓ U.S. Stock Research & Analysis
- ✓ Delivered every Friday
- ✓ Company & Industry Analysis
- ✓ Full Historical Report Access
A$5000.00/ 12 months
Risk:Medium
Subscribe Now →
